Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imaging in Ectopic Cushing Syndrome
NCT02019706Phase 2Recruiting
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Feb 2014
- Primary completion
- Dec 2030
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gallium ga 68 dotatate, Fluorodopa F 18 in Cushing syndrome, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Feb 2014; status: recruiting.
02
Drugs
gallium ga 68 dotatateFluorodopa F 18
03
Conditions
Cushing syndrome
Beyond the preview
Go deeper on NCT02019706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02019706.